The effect of nateglinide stimulated insulin secretion on post challenge glucose and lipid metabolism in Type 2 diabetes
Main Authors: | Mohanlal, N, Holman, R |
---|---|
Format: | Conference item |
Udgivet: |
2002
|
Lignende værker
-
Nateglinide, but not repaglinide, stimulates growth hormone secretion from rat pituitary cells.
af: Bokvist, K, et al.
Udgivet: (2000) -
Effect of nateglinide on the incidence of diabetes and cardiovascular events.
af: Holman, R, et al.
Udgivet: (2010) -
A review of nateglinide in the management of patients with type 2 diabetes
af: Nicholas Tentolouris, et al.
Udgivet: (2008-01-01) -
Randomized dose ranging study of the reduction of fasting and postprandial glucose in type 2 diabetes by nateglinide (A-4166).
af: Gribble, F, et al.
Udgivet: (2001) -
Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial.
af: Califf, R, et al.
Udgivet: (2008)